文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Statins and Lp(a): do not make perfect the enemy of excellent.

作者信息

Banach Maciej, Penson Peter E

机构信息

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Zeromskiego 113, Lodz, Poland.

Polish Mother's Memorial Hospital Research Institute (PMMHRI), Rzgowska 281/289, Lodz, Poland.

出版信息

Eur Heart J. 2020 Jan 1;41(1):190-191. doi: 10.1093/eurheartj/ehz775.

DOI:10.1093/eurheartj/ehz775

Abstract

摘要

相似文献

[1]

Statins and Lp(a): do not make perfect the enemy of excellent.

Eur Heart J. 2020-1-1

[2]

Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials.

BMC Med. 2017-2-3

[3]

[How to deal ugly twins, LDL-cholesterol and lipoprotein (a)].

Vnitr Lek. 2016

[4]

Statins and Lp(a): The plot thickens.

Atherosclerosis. 2019-10

[5]

Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk?

Curr Atheroscler Rep. 2019-3-7

[6]

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Circulation. 1989-11

[7]

Statins increase Lp(a) plasma level: is this clinically relevant?

Eur Heart J. 2020-6-21

[8]

Biology, pathophysiology and current therapies that affect lipoprotein (a) levels.

J Mol Cell Cardiol. 2019-4-12

[9]

Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.

Atherosclerosis. 2015-9

[10]

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

Atherosclerosis. 2017-6-15

引用本文的文献

[1]

2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.

Arch Med Sci. 2025-2-22

[2]

2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.

Arch Med Sci. 2024-3-18

[3]

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.

Arch Med Sci. 2024-1-31

[4]

Lipoprotein(a): the enemy that we still don't know how to defeat.

Eur Heart J Open. 2023-8-27

[5]

Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases.

Arch Med Sci. 2021-3-15

[6]

Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy.

Pharmaceuticals (Basel). 2022-12-16

[7]

The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events.

Eur Heart J Open. 2022-6-14

[8]

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Arch Med Sci. 2021-11-8

[9]

The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.

Curr Atheroscler Rep. 2020-9-18

[10]

Lipoprotein(a) Lowering-From Lipoprotein Apheresis to Antisense Oligonucleotide Approach.

J Clin Med. 2020-7-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索